Ferrara, Rosarita
Ientile, Valentina
Piccinni, Carlo
Pasqua, Alessandro
Pecchioli, Serena
Fontana, Andrea
Alecci, Umberto
Scoglio, Riccardo
Magliozzo, Francesco
Torrisi, Sebastiano Emanuele
Vancheri, Carlo
Vitulo, Patrizio
Fantaci, Giovanna
Ferrajolo, Carmen
Cazzola, Mario
Cricelli, Claudio
Caputi, Achille Patrizio
Trifirò, Gianluca
Article History
Received: 21 August 2017
Revised: 7 February 2018
Accepted: 16 February 2018
First Online: 23 March 2018
Competing interests
: G.T. coordinates a Master programme on use of real world data for pharmacoepidemiology and leads an academic team of pharmacoepidemiologists conducting several projects for which University of Messina receives unconditional grants from various pharmaceutical companies. In addition, G.T. was part of the Virtual Advisory Board on Smart devices and telehealth solutions in COPD, which was funded by Novartis. Mario Cazzola has participated as a speaker, and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Kamada, Menarini Group, Lallemand, Mundipharma, Novartis, Pfizer, Verona Pharma, and Zambon, and is or has been a consultant to Chiesi Farmaceutici, Lallemand, Novartis, Verona Pharma, and Zambon.